Central Pharma sees losses for 3rd year

By Star Business Report
6 November 2022, 18:00 PM
UPDATED 7 November 2022, 05:14 AM
Central Pharmaceuticals Ltd suffered losses for the third consecutive year in 2021-22.  

Central Pharmaceuticals Ltd suffered losses for the third consecutive year in 2021-22.  

It incurred a loss of Tk 6.83 crore in the year that ended on June 30 this year. The loss stood at Tk 83.86 lakh in 2020-21.

Thus, the drugs maker reported earnings per share of Tk 0.57 in negative for 2021-22, which was Tk 0.07 in negative in 2020-21.

The net asset value per share of Central Pharmaceuticals dropped to Tk 5.96 from Tk 6.53 a year earlier.

The net operating cash flow per share was Tk 0.01 in negative in 2021-22 from a positive Tk 0.01 a year earlier. The board did not recommend dividends for 2021-22.

Shares of Central Pharma closed unchanged at Tk 12.40 on the Dhaka Stock Exchange yesterday.